513 related articles for article (PubMed ID: 3016712)
21. Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism.
Holers VM; Chaplin DD; Leykam JF; Gruner BA; Kumar V; Atkinson JP
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2459-63. PubMed ID: 3031685
[TBL] [Abstract][Full Text] [Related]
22. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
Cohen JH; Fischer E; Kazatchkine MD; Lenoir GM; Lefevre-Delvincourt C; Revillard JP
Scand J Immunol; 1987 Jun; 25(6):587-98. PubMed ID: 3037684
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).
Fingeroth JD; Clabby ML; Strominger JD
J Virol; 1988 Apr; 62(4):1442-7. PubMed ID: 2831405
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript.
Sinha SK; Todd SC; Hedrick JA; Speiser CL; Lambris JD; Tsoukas CD
J Immunol; 1993 Jun; 150(12):5311-20. PubMed ID: 8390533
[TBL] [Abstract][Full Text] [Related]
25. Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1.
Quigg RJ; Holers VM
J Immunol; 1995 Aug; 155(3):1481-8. PubMed ID: 7636211
[TBL] [Abstract][Full Text] [Related]
26. A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP.
Rey-Campos J; Rubinstein P; Rodriguez de Cordoba S
J Exp Med; 1988 Feb; 167(2):664-9. PubMed ID: 2450163
[TBL] [Abstract][Full Text] [Related]
27. Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1.
Hourcade D; Miesner DR; Atkinson JP; Holers VM
J Exp Med; 1988 Oct; 168(4):1255-70. PubMed ID: 2971757
[TBL] [Abstract][Full Text] [Related]
28. CRRP: a guinea pig protein, identified by sequence homology to human CR1, which contains two short consensus repeat motifs and appears not to be transmembrane or secreted.
Moore FD
J Immunol; 1991 Nov; 147(10):3615-22. PubMed ID: 1834743
[TBL] [Abstract][Full Text] [Related]
29. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
[TBL] [Abstract][Full Text] [Related]
30. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of complement C3 receptors on human astrocytes.
Gasque P; Chan P; Mauger C; Schouft MT; Singhrao S; Dierich MP; Morgan BP; Fontaine M
J Immunol; 1996 Mar; 156(6):2247-55. PubMed ID: 8690915
[TBL] [Abstract][Full Text] [Related]
32. The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands.
Furtado PB; Huang CY; Ihyembe D; Hammond RA; Marsh HC; Perkins SJ
J Mol Biol; 2008 Jan; 375(1):102-18. PubMed ID: 18028942
[TBL] [Abstract][Full Text] [Related]
33. Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities.
Weis JJ; Richards SA; Smith JA; Fearon DT
J Immunol Methods; 1986 Aug; 92(1):79-87. PubMed ID: 3018085
[TBL] [Abstract][Full Text] [Related]
34. Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21).
Fearon DT; Ahearn JM
Curr Top Microbiol Immunol; 1990; 153():83-98. PubMed ID: 2153507
[No Abstract] [Full Text] [Related]
35. Loss of human CR1- and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations.
Holguin MH; Kurtz CB; Parker CJ; Weis JJ; Weis JH
J Immunol; 1990 Sep; 145(6):1776-81. PubMed ID: 2144008
[TBL] [Abstract][Full Text] [Related]
36. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
Kazatchkine MD; Fearon DT
Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
[TBL] [Abstract][Full Text] [Related]
37. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor.
Fujisaku A; Harley JB; Frank MB; Gruner BA; Frazier B; Holers VM
J Biol Chem; 1989 Feb; 264(4):2118-25. PubMed ID: 2563370
[TBL] [Abstract][Full Text] [Related]
38. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
Kalli KR; Hsu PH; Bartow TJ; Ahearn JM; Matsumoto AK; Klickstein LB; Fearon DT
J Exp Med; 1991 Dec; 174(6):1451-60. PubMed ID: 1836011
[TBL] [Abstract][Full Text] [Related]
39. Structural analysis of human complement protein H: homology with C4b binding protein, beta 2-glycoprotein I, and the Ba fragment of B2.
Kristensen T; Wetsel RA; Tack BF
J Immunol; 1986 May; 136(9):3407-11. PubMed ID: 2937845
[TBL] [Abstract][Full Text] [Related]
40. A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2.
Molina H; Kinoshita T; Inoue K; Carel JC; Holers VM
J Immunol; 1990 Nov; 145(9):2974-83. PubMed ID: 2145366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
